...@med.cornell.edu Primary Investigator(s) John P Leonard, MD Protocol ID(s) Weill Cornell Medicine IRB...
https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1b3-double-blind-randomized-active-controlled-3-stage-biomarker-adaptive-study-of-tazemetostat-or-placebo-in-combination-with-lenalidomide-plus-rituximab-in-subjects-with-relapsedrefractory-follicular-lymphoma
... Leonard N. Girardi 7/1994 6/1996 Chair, O. Wayne Isom Professor, Cardiothoracic Surgery , Department...
https://ctsurgery.weillcornell.org/education/residency/our-distinguished-alumni
... A, Pearse R, Gertz MA, Leonard J, Lacy MQ et al.. 2010. Clarithromycin (Biaxin)-lenalidomide-low-dose...
https://www.myelomacenter.org/research-and-clinical-trials/bibliography?page=1&s=type&o=desc
..., Coleman M, Kumar S, Mark T, Dispenzieri A, Pearse R, Gertz MA, Leonard J, Lacy MQ et al.. 2010...
https://www.myelomacenter.org/research-and-clinical-trials/bibliography?page=1&s=title&o=desc
..., Leonard JP, Niesvizky R. 2009. Milatuzumab: a promising new agent for the treatment of lymphoid...
https://www.myelomacenter.org/research-and-clinical-trials/bibliography?page=1&s=author&o=asc
.... Mark T, Martin P, Leonard JP, Niesvizky R. 2009. Milatuzumab: a promising new agent...
https://www.myelomacenter.org/research-and-clinical-trials/bibliography?page=1&s=type&o=asc
... and dexamethasone therapy.. Br J Haematol. 138(5):640-3. M Mark T, Martin P, Leonard JP, Niesvizky R. 2009...
https://www.myelomacenter.org/research-and-clinical-trials/bibliography?page=1&s=title&o=asc
... Howard, Dr. John Leonard, Dr. Keith Hentel, Dr. Paraskevi Giannakakou, Dr. Rache Simmons, Dr. Rahul...
https://news.weill.cornell.edu/units/psychiatry
... Cardiology, Dr. Bruce Lerman, Dr. John Leonard, Dr. Jonathan Weinsaft, Institutional, NewYork...
https://news.weill.cornell.edu/units/newyork-presbyterian
... full article Dr. Bobak Modasegh, Dr. Conor Liston, Dr. Denise Howard, Dr. John Leonard, Dr. Keith...
https://news.weill.cornell.edu/units/emergency-medicine
